Literature DB >> 10728411

Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy.

D Jarreta1, J Orús, A Barrientos, O Miró, E Roig, M Heras, C T Moraes, F Cardellach, J Casademont.   

Abstract

OBJECTIVE: To study the mitochondrial respiratory chain enzyme activities in patients with idiopathic dilated cardiomyopathy (IDC).
METHODS: Mitochondrial respiratory chain enzyme activities were assessed spectrophotometrically in left ventricular tissue of 17 patients with IDC undergoing cardiac transplantation, as well as in two groups of controls: a group of six patients suffering from ischemic dilated cardiomyopathy (IC) also undergoing cardiac transplantation, and a group of 17 organ donors considered normal from a cardiac point of view. Cytochrome b gene from three IDC patients whose complex III activity was particularly low and from three controls was also sequenced.
RESULTS: We found that complex III enzymatic activity was lower not only in IDC but also in IC patients when compared with normal controls. When analysing cytochrome b gene we only found neutral polymorphisms previously described.
CONCLUSIONS: In view of such results, we believe that the decrease of respiratory chain complex III activity found in some cases of IDC is a secondary phenomenon, and not due to a primary mitochondrial disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728411     DOI: 10.1016/s0008-6363(99)00388-0

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  63 in total

1.  Organization of mammalian cytoplasm.

Authors:  Alice Hudder; Lubov Nathanson; Murray P Deutscher
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

2.  Nuclear protein synthesis: a re-evaluation.

Authors:  Lubov Nathanson; Tianli Xia; Murray P Deutscher
Journal:  RNA       Date:  2003-01       Impact factor: 4.942

3.  Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways.

Authors:  Nisha Garg; Arpad Gerstner; Vandanajay Bhatia; James DeFord; John Papaconstantinou
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

Review 4.  Mitochondria in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  Cardiovasc Res       Date:  2010-07-28       Impact factor: 10.787

5.  Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload.

Authors:  Xueshan Gao; Mingwei Qian; Jian Li Campian; James Marshall; Zhanxiang Zhou; Andrew M Roberts; Y James Kang; Sumanth D Prabhu; Xiao-Feng Sun; John W Eaton
Journal:  Free Radic Biol Med       Date:  2010-05-05       Impact factor: 7.376

6.  Role of mitochondrial respiratory chain complex III in high glucose peritoneal dialysate-induced hyperpermeability of HPMCs.

Authors:  Xuejing Zhu; Guanghui Ling; Li Xiao; Yinhong Liu; Shaobin Duan; Youming Peng; Yashpal S Kanwar; Lin Sun; Fuyou Liu
Journal:  Ren Fail       Date:  2010       Impact factor: 2.606

Review 7.  Mitochondrial centrality in heart failure.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  Heart Fail Rev       Date:  2008-01-05       Impact factor: 4.214

8.  Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion.

Authors:  Yong Seon Choi; Ana Barbosa Marcondes de Mattos; Dan Shao; Tao Li; Miranda Nabben; Maengjo Kim; Wang Wang; Rong Tian; Stephen C Kolwicz
Journal:  J Mol Cell Cardiol       Date:  2016-09-28       Impact factor: 5.000

9.  Divergent mitochondrial biogenesis responses in human cardiomyopathy.

Authors:  Preeti Ahuja; Jonathan Wanagat; Zhihua Wang; Yibin Wang; David A Liem; Peipei Ping; Igor A Antoshechkin; Kenneth B Margulies; W Robb Maclellan
Journal:  Circulation       Date:  2013-04-15       Impact factor: 29.690

Review 10.  Dynamic organization of mitochondria in human heart and in myocardial disease.

Authors:  Charles L Hoppel; Bernard Tandler; Hisashi Fujioka; Alessandro Riva
Journal:  Int J Biochem Cell Biol       Date:  2009-05-14       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.